Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEffects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia
European Urology, 09/17/09
Porst H et al. – Once–daily tadalafil improved erectile function in sexually active men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia. Improvement appeared both overall and in clinically relevant patient subgroups. These data support the use of once–daily tadalafil in this population.
Related Articles
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 82%
Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09
Relevance Score: 82%
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/23/09
Relevance Score: 80%
Studies show Viagra, other drugs outperform hormone treatment
Internet Source, 10/21/09
Relevance Score: 79%
Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction a Double-Blind, Placebo-Controlled Clinical Trial
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 79%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
British Journal of Clinical Pharmacology, 12/09/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Association between incidence of acute exacerbation and medication therapies in patients with COPD
Current Medical Research and Opinion, 12/10/09
Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective
Current Medical Research and Opinion, 12/10/09
Preparation, characterization and taste-masking properties of microspheres containing azithromycin
Journal of Pharmacy and Pharmacology, 12/10/09
Sponsor
Article Search
Sponsor